195 related articles for article (PubMed ID: 33255934)
1. Urinary Metabolomic Profiling in Streptozotocin-Induced Diabetic Mice after Treatment with Losartan.
Hyeon JS; Jung Y; Lee G; Ha H; Hwang GS
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255934
[TBL] [Abstract][Full Text] [Related]
2. Metabolic changes in urine and serum during progression of diabetic kidney disease in a mouse model.
Kim NH; Hyeon JS; Kim NH; Cho A; Lee G; Jang SY; Kim MK; Lee EY; Chung CH; Ha H; Hwang GS
Arch Biochem Biophys; 2018 May; 646():90-97. PubMed ID: 29621522
[TBL] [Abstract][Full Text] [Related]
3. Metabolomic analysis and biochemical changes in the urine and serum of streptozotocin-induced normal- and obese-diabetic rats.
Mediani A; Abas F; Maulidiani M; Abu Bakar Sajak A; Khatib A; Tan CP; Ismail IS; Shaari K; Ismail A; Lajis NH
J Physiol Biochem; 2018 Aug; 74(3):403-416. PubMed ID: 29766441
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic signatures and microbial community profiling of depressive rat model induced by adrenocorticotrophic hormone.
Song J; Ma W; Gu X; Zhao L; Jiang J; Xu Y; Zhang L; Zhou M; Yang L
J Transl Med; 2019 Jul; 17(1):224. PubMed ID: 31307473
[TBL] [Abstract][Full Text] [Related]
5. Metabolic effects of basic fibroblast growth factor in streptozotocin-induced diabetic rats: A
Lin X; Zhao L; Tang S; Zhou Q; Lin Q; Li X; Zheng H; Gao H
Sci Rep; 2016 Nov; 6():36474. PubMed ID: 27808173
[TBL] [Abstract][Full Text] [Related]
6.
Tian JS; Zhao L; Shen XL; Liu H; Qin XM
Chin J Nat Med; 2018 Apr; 16(4):261-270. PubMed ID: 29703326
[TBL] [Abstract][Full Text] [Related]
7. Systemic and characteristic metabolites in the serum of streptozotocin-induced diabetic rats at different stages as revealed by a (1)H-NMR based metabonomic approach.
Diao C; Zhao L; Guan M; Zheng Y; Chen M; Yang Y; Lin L; Chen W; Gao H
Mol Biosyst; 2014 Mar; 10(3):686-93. PubMed ID: 24448714
[TBL] [Abstract][Full Text] [Related]
8. Metabolomic signature of type 1 diabetes-induced sensory loss and nerve damage in diabetic neuropathy.
Rojas DR; Kuner R; Agarwal N
J Mol Med (Berl); 2019 Jun; 97(6):845-854. PubMed ID: 30949723
[TBL] [Abstract][Full Text] [Related]
9. [Metabolomics study of Danggui Buxue Tang on treatment of type 2 diabetes mice using UHPLC-Q-TOF-MS].
Sun LL; Bai HY; Zheng WH; Wang LY; Zhao W; Li JY; Shi YB; Yang ZG
Zhongguo Zhong Yao Za Zhi; 2020 Feb; 45(3):636-644. PubMed ID: 32237524
[TBL] [Abstract][Full Text] [Related]
10. Grading of endometrial cancer using
Skorupa A; Poński M; Ciszek M; Cichoń B; Klimek M; Witek A; Pakuło S; Boguszewicz Ł; Sokół M
Sci Rep; 2021 Sep; 11(1):18160. PubMed ID: 34518615
[TBL] [Abstract][Full Text] [Related]
11. Clinical metabolomics characteristics of diabetic kidney disease: A meta-analysis of 1875 cases with diabetic kidney disease and 4503 controls.
Yuan Y; Huang L; Yu L; Yan X; Chen S; Bi C; He J; Zhao Y; Yang L; Ning L; Jin H; Yang R; Li Y
Diabetes Metab Res Rev; 2024 Mar; 40(3):e3789. PubMed ID: 38501707
[TBL] [Abstract][Full Text] [Related]
12. A high-throughput metabolomic approach to explore the regulatory effect of mangiferin on metabolic network disturbances of hyperlipidemia rats.
Zhou C; Li G; Li Y; Gong L; Huang Y; Shi Z; Du S; Li Y; Wang M; Yin J; Sun C
Mol Biosyst; 2015 Feb; 11(2):418-33. PubMed ID: 25406416
[TBL] [Abstract][Full Text] [Related]
13. UPLC-MS-based urine nontargeted metabolic profiling identifies dysregulation of pantothenate and CoA biosynthesis pathway in diabetic kidney disease.
Ma T; Liu T; Xie P; Jiang S; Yi W; Dai P; Guo X
Life Sci; 2020 Oct; 258():118160. PubMed ID: 32730837
[TBL] [Abstract][Full Text] [Related]
14. Metabolic changes associated with papillary thyroid carcinoma: A nuclear magnetic resonance-based metabolomics study.
Li Y; Chen M; Liu C; Xia Y; Xu B; Hu Y; Chen T; Shen M; Tang W
Int J Mol Med; 2018 May; 41(5):3006-3014. PubMed ID: 29484373
[TBL] [Abstract][Full Text] [Related]
15. Changes in hepatic metabolic profile during the evolution of STZ-induced diabetic rats via an
Chen M; Zheng H; Xu M; Zhao L; Zhang Q; Song J; Zhao Z; Lu S; Weng Q; Wu X; Yang W; Fan X; Gao H; Ji J
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30918104
[No Abstract] [Full Text] [Related]
16. Time-based investigation of urinary metabolic markers for Type 2 diabetes: Metabolomics approach for diabetes management.
Hanafy MM; Lindeque JZ; El-Maraghy SA; Abdel-Hamid AZ; Shahin NN
Biofactors; 2021 Jul; 47(4):645-657. PubMed ID: 33836111
[TBL] [Abstract][Full Text] [Related]
17. Investigating correlations in the altered metabolic profiles of obese and diabetic subjects in a South Indian Asian population using an NMR-based metabolomic approach.
Gogna N; Krishna M; Oommen AM; Dorai K
Mol Biosyst; 2015 Feb; 11(2):595-606. PubMed ID: 25464928
[TBL] [Abstract][Full Text] [Related]
18. Proteomic and metabolomic characterization of streptozotocin-induced diabetic nephropathy in TIMP3-deficient mice.
Rossi C; Marzano V; Consalvo A; Zucchelli M; Levi Mortera S; Casagrande V; Mavilio M; Sacchetta P; Federici M; Menghini R; Urbani A; Ciavardelli D
Acta Diabetol; 2018 Feb; 55(2):121-129. PubMed ID: 29134286
[TBL] [Abstract][Full Text] [Related]
19. Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease: a targeted metabolomics study using nuclear magnetic resonance.
Kwon S; Hyeon JS; Jung Y; Li L; An JN; Kim YC; Yang SH; Kim T; Kim DK; Lim CS; Hwang GS; Lee JP
Kidney Res Clin Pract; 2023 Jul; 42(4):445-459. PubMed ID: 37551126
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
